- Thursday, May 4, 2023
8:00 AM – 8:15 AM ET
Welcome and Introduction
8:00 AM – 8:15 AM ET
Welcome and IntroductionTime Zone: ETCo-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Co-Chair###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Co-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 8:15 AM – 9:00 AM ET
Session 8: Update in Vulvar and Vaginal Cancers
8:15 AM – 9:00 AM ET
Session 8: Update in Vulvar and Vaginal CancersPresenter: – Florida International University
Brian Slomovitz, MD – Florida International University ### 1186890###Presenter###Professor###Florida International University###Presenter: – Florida International University
### 9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
Time Zone: ET
9:15 AM – 9:50 AM ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics
9:15 AM – 9:50 AM ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted TherapeuticsTime Zone: ETPresenter: – University of New Mexico Cancer Center
Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center ### 1953572###Presenter###Associate Professor, Gynecologic Oncology###University of New Mexico Cancer Center###Presenter: – University of New Mexico Cancer Center
### she/her/hers9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Speaker: – University of New Mexico Cancer Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center ### 1953572###Speaker###Associate Professor, Gynecologic Oncology###University of New Mexico Cancer Center###Speaker: – University of New Mexico Cancer Center
### she/her/hers10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
Time Zone: ET
10:15 AM – 11:15 AM ET
Exploring a Non-Chemotherapy Treatment Option for Patients With Certain Types of Advanced Endometrial Carcinoma
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
Time Zone: ET
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
Time Zone: ET
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in Oncology
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in OncologyTime Zone: ETPresenter: – University of Oklahoma
Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###Presenter: – University of Oklahoma
### she/her/hers12:05 PM – 12:15 PM ET
Live Q&A
12:05 PM – 12:15 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – University of Oklahoma
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###Presenter: – University of Oklahoma
### she/her/hers12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
Time Zone: ET
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent Meetings
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent MeetingsTime Zone: ETPresenter: – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###Presenter: – University of California, San Diego
### 1:05 PM – 1:15 PM ET
Live Q&A
1:05 PM – 1:15 PM ET
Live Q&ATime Zone: ETModerator: – Sarah Cannon Research Institute (SCRI)
Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – University of California, San Diego
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###Moderator: – Sarah Cannon Research Institute (SCRI)
### @@@ Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###Presenter: – University of California, San Diego
### 1:15 PM – 1:35 PM ET
Break
1:15 PM – 1:35 PM ET
Break
Time Zone: ET
1:35 PM – 1:50 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors - PRO
1:35 PM – 1:50 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors - PROTime Zone: ETPresenter: – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###Presenter: – University of California, San Diego
### 1:50 PM – 2:05 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors - CON
1:50 PM – 2:05 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors - CONTime Zone: ETSpeaker: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Speaker###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Speaker: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
### 2:05 PM – 2:25 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors
2:05 PM – 2:25 PM ET
Session 12: Debate: Endometrial Cancer Treatment Debate: Checkpoint Inhibitors for All vs Individualized Therapies Beyond Checkpoint Inhibitors - DISCUSSIONTime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Panelist: – University of California, San Diego
Panelist: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Ramez Eskander, MD – University of California, San Diego ### 1416358###Panelist###Associate Professor###University of California, San Diego###Panelist: – University of California, San Diego
### @@@ Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Panelist###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Panelist: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
### 2:25 PM – 2:45 PM ET
Break
2:25 PM – 2:45 PM ET
Break
Time Zone: ET
2:45 PM – 3:20 PM ET
Session 13: Collateral Damage: Side Effects of Breast Cancer Treatment
2:45 PM – 3:20 PM ET
Session 13: Collateral Damage: Side Effects of Breast Cancer TreatmentTime Zone: ETPresenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Presenter###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###Presenter: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
### 3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&ATime Zone: ETModerator: – Sarah Cannon Research Institute (SCRI)
Speaker: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###Moderator: – Sarah Cannon Research Institute (SCRI)
### @@@ Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Speaker###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###Speaker: – Texas Oncology -Baylor Charles A. Sammons Cancer Center
### 3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
Time Zone: ET
3:45 PM – 4:20 PM ET
Session 14: ADCs: A New Technology
3:45 PM – 4:20 PM ET
Session 14: ADCs: A New TechnologyPresenter: – European Insitute of Oncology, IRCCS and University of Milano
Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Presenter###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###Presenter: – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his4:20 PM – 4:30 PM ET
Live Q&A
4:20 PM – 4:30 PM ET
Live Q&AModerator: – Sarah Cannon Research Institute (SCRI)
Speaker: – European Insitute of Oncology, IRCCS and University of Milano
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###Moderator: – Sarah Cannon Research Institute (SCRI)
### @@@ Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Speaker###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###Speaker: – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
Time Zone: ET
4:45 PM – 5:20 PM ET
Session 15: Updates in HR-Positive Breast Cancer
4:45 PM – 5:20 PM ET
Session 15: Updates in HR-Positive Breast CancerTime Zone: ETPresenter: – Winship Cancer Institute at Emory University
Kevin Kalinsky, MD, MS (he/him/his) – Winship Cancer Institute at Emory University ### 1538154###Presenter###Director, Glenn Family Breast Center###Winship Cancer Institute at Emory University###Presenter: – Winship Cancer Institute at Emory University
### he/him/his5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&ATime Zone: ETModerator: – European Insitute of Oncology, IRCCS and University of Milano
Speaker: – Winship Cancer Institute at Emory University
Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Moderator###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###Moderator: – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his @@@ Kevin Kalinsky, MD, MS (he/him/his) – Winship Cancer Institute at Emory University ### 1538154###Speaker###Director, Glenn Family Breast Center###Winship Cancer Institute at Emory University###Speaker: – Winship Cancer Institute at Emory University
### he/him/his
